Hepatobiliary Pancreat Dis Int  2024, Vol. 23 Issue (3): 326-330 DOI: 10.1016/j.hbpd.2023.10.004 |
|
|||
| Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment | |||
| Feng Zhu a , b , # , Yi-Ming Wang a , # , Ming Ni a , # , Yuan Liang a , Jie-Hui Huang b , Xue-Hao Wang a , Feng Cheng a , Ling Lu a , c , ∗ | |||
| a Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Liver Transplantation, Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing 210000, China b Department of Respiratory and Critical Care Medicine, Wuxi Fifth People’s Hospital, Wuxi 214000, China c Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 210000, China ∗ Corresponding author at: Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210 0 0 0, China E-mail address: lvling@njmu.edu.cn (L. Lu) . # Contributed equally. |
|||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
